SlideShare a Scribd company logo
Rare Urological Cancers Professor Vesa V Kataja Head of Department Cancer Center, UEF / KUH Kuopio, FINLAND Kuopio University Hospital
Rare Renal Cancers ,[object Object],Human renal epithelial neoplasms – genetic traits Histology Clear cell Papillary type 1 Papillary type 2 Chromophobe Oncocytoma Frequency 75 % 5 % 10 % 5 % 5 % Gene VHL Met FH Birt-Hogg-Dube ’ Clinical presentation  - tumours in multiple organs - 40 % deve-lop RCC -  HPRC , bilateral, multifocal papillary  renal carcinoma -  HLRCC , cutaneous or uterine leiomyoma - often aggressive  - fibrofolliculoma, pulmonary cysts, multifocal and bilateral renal tumours (oncocytic 50 % chromo-phobic 33 %, clear cell 10 %, onco-cytoma 7 %)
Rare Renal Cancers 15 % Histological subtypes of sporadic renal cell cancer Histology Prognosis Note ,[object Object],70 % @ 5 yrs Mutated  VHL  common  Papillary type 1 80 % @ 10 yrs Papillary type 2 60 % @ 10 yrs Outcome studies limited Chromophobe Good ” malignant oncocytoma” ? Oncocytoma Excellent Benign Collecting duct 14 % @ 10 yrs Rare (1 %) and aggressive Medullary Median survival 4.5 mths (95 % metastatic @ dg) Rare and very aggressive  Black race, all sickle cell trait/disease, mean age 19 yrs Sarcomatoid variant Median survival 6.6 mths Rare, aggressive variant of many histological subtypes
Rare Renal Cancers *Not in WHO 2004 classification Histological subtypes of sporadic renal cell cancer Histology/Entity Prognosis Note ,[object Object],Behaves mainly in low-grade fashion Female:Male = 4 : 1 Translocation carcinoma (Transcription factor  TFE3, TFEB ) TFE3  have indolent course despite advanced stage @ dg Children and young adults (median age 20 yrs) Generally large @ dg Post-neuroblastoma carcinoma Not established, affects longevity of life Mean interval 9 yrs from NB to RCC (risk > 300-fold) Tubulocystic carcinoma* Not established; mainly on the better side – most pT1 @ dg Male:Female = 7:1 Subset of papillary RCC?
Rare Renal Cancers *Not in WHO 2004 classification Histological subtypes of sporadic renal cell cancer Histology/Entity Prognosis Note End-stage renal disease associated carcinoma* 40 – 100 x the risk of general population Depends on histopathological subtype Spectrum of recognised types Two novel neoplasia 1) Cystic disease associated RCC 2) Papillary clear cell RCC Follicular RC* Good Note! metastatic follicular carcinoma of the thyroid Clear cell papillary and cystic RCC* Excellent TFE3  negative Oncocytic papillary RCC* Not established; mainly on better side  Genetically similar to papillary RCC type 1 and 2 (trisomy 7, 17, loss of Y in FISH); male predominance  (87 %)
Umberto Capitanio et al., BJU Int 103:1496-1500;2009
Rare Renal Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],Renal carcinoid with CgA positivity Mazzucchelli R., et al. BJU Int 2009
Rare Renal Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rare Renal Cancers ,[object Object],[object Object],[object Object],[object Object],Large cells with intense synaptophysin positivity Dundr P et al., Pathol Oncol Res 2010
Cancer of the Renal Pelvis and Ureter ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Cancer of the Renal Pelvis and Ureter - TREATMENT - ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Hall MC et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology1998;52:594 Five-Year Disease-Specific Survival by Stage after Surgical Resection of Transitional Cell Carcinoma of the Upper Urinary Tract (77 % open surgery) Stage No  % ,[object Object],38 100 pT1 99 92 pT2 34 73 pT3 53 41 pT4 19 0
Cancer of the Renal Pelvis and Ureter - TREATMENT - ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rare Urothelial Bladder Cancers Variants of invasive urothelial carcinoma Squamous differentiation Glandular differentiation Nested pattern Microcystic Micropapillary Lymphoepithelioma-like Plasmacytoid and lymphoma-like Sarcomatoid/carcinosarcoma Giant cell Trophoblastic differentiation Clear cell Lipid cell Undifferentiated Adapted from the World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs Compared to pure urothelial cancers: - Higher clinical stage at presentation - More likely to be invasive
Rare Non-urothelial Bladder Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-urothelial Bladder Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1 Scosyrev et al., Urology 2009 (SEER Data) 2 Zaghloul et al., IJROBP, 1992 3 Gad el Mawla et al., Ann Oncol 1991 *NOTE! Trials on bilharzial SCC
Non-urothelial Bladder Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1 Ghaneim MA et al., J Urol 1997 2 Wright JL et al., Cancer 2006 3 Siefker-Radtke A. Expert Rev Anticancer Ther 2006 Urachus
Non-urothelial Bladder Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1 World Health Organization Classification of Tumours, 2004 2 Black PC et al., Urol Oncol 2009 3 Mackey JR et al., J Urol 1998
Non-urothelial Bladder Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-urothelial Bladder Cancers SARCOMAS Leiomyosarcoma Most common adult sarcoma in bladder. Male predominance 2:1. Post cyclophospamide (5 – 20 yrs). Aggressive neoplasm ,[object Object],Most common bladder malignancy of childhood and adolescence. Embryonal, botryoid and alveolar variants. Post therapy at 6.1 yrs 40 % retaining functional bladder, survival rate 82 % (not incl. those with disseminated disease @ dg)  Angiosarcoma Exceedingly rare and carries a poor prognosis: 70 % die within two years. Metastases to lungs and liver frequent Malignant fibrous histiocytoma (MFH) Predominantly in men in their 50s – 80s. Often large at presentation involving full thickness of bladder wall. Very aggressive with high local recurrence rate and metastases Carcinosarcoma Malignant epithelial neoplasms with a neoplastic spindle cell component. Post RT and cyclophospamide.  Alveolar soft-part sarcoma The only case identified in the bladder of a 25-year-old woman  (Amin MB, et al., Am J Surg Pathol, 2006) Other sarcomas Liposarcoma, chondrosarcoma, Kaposi sarcoma, Sarcoma NOS
Non-urothelial Bladder Cancers OTHER Carcinoid Around 20 reported cases. Not associated with carcinoid syndrome. Submucosal. 25 % present with lymph node or distant metatases. Local disease cured by excision  ,[object Object],Anecdotal cases. Equally aggressive to small cell carcinoma Primitive neuroectodermal tumour (PNET) Rare case reports. Highly aggressive, rapidly growing! Shares the same chromosomal abnormalities with Ewing sarcoma Malignant peripheral nerve sheat tumour (MPNST) Only a few cases documented. Dg < 40 years. Associated with NF type 1, possibly originating in nerve sheat neurofibromas in autonomic nerve plexuses in bladder wall. Highly malignant.  Hemangiopericytoma Rare case reports in adults in their mid-40’s. Slowly growing painless mass. Microscopically benign appearance, yet 50 % develop metastases
Prostate Cancer ,[object Object],[object Object],[object Object],[object Object],[object Object],Almost all PCs show focal neuroendocrine differentiation as evident by CgA, serotonin, NSE, synaptophysin or bombesin/gastrin releasing peptide positivity
Rare Prostate Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rare Prostate Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Morgan TM et al., J Urol 2010
Rare Prostate Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rare Prostate Cancers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rare Prostate Cancers PSA negative staining of the tumour Carcinoma strongly positive for synaptophysin ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Rare Prostate Cancers OTHER Large cell neuroendocrine carcinoma (LCNEC) Few described. Can be mistaken for Gleason 5+5 adenocarcinoma. Strong positivity for CD56, C57, CgA, synaptophysin. Strong bcl-2 overexpression, expression of MIB-1 and p53 in > 50 % of nuclei, negative AR staining. Prognosis = small cell carcinoma ,[object Object],signet-ring adenocarcinoma. Aggressive, very uncommon Mucinous (colloid) adenocarcinomas Characterised by large pools of extracellular mucin that by definition compose at least 25 % of the tumor volume. Represent approximately 0.4 % of all prostate adenocarcinomas. Considered more aggressive than non-mucinous adenocarcinoma.  Sarcomas Highly aggressive. Leiomyosarcoma most common (0.1 % of prostate malignancies). Therapeutic options with efficacy are limited Lymphomas Rare. often with extraprostatic disease. Presents in all possible phenotypes. Treatment according to lymphoma protocols
Carcinoma of the Urethra  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Carcinoma of the urethra  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Kuopio Thank you!

More Related Content

What's hot

Urothelial ca urinary markers
Urothelial ca urinary markersUrothelial ca urinary markers
Urothelial ca urinary markers
GAURAV NAHAR
 
Recent advances in colorectal carcinoma
Recent advances in colorectal carcinomaRecent advances in colorectal carcinoma
Recent advances in colorectal carcinoma
Vikash Prasad
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
Mohammed Fathy
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinomadamuluri ramu
 
Carcinoma of Unknown Primary (COUP)
Carcinoma of Unknown Primary (COUP)Carcinoma of Unknown Primary (COUP)
Carcinoma of Unknown Primary (COUP)
Dr.Shriniwas Bhawana Rishi
 
Carcinoma of unknown primary origin (cup) 198
Carcinoma of unknown primary origin (cup) 198Carcinoma of unknown primary origin (cup) 198
Carcinoma of unknown primary origin (cup) 198Shekhar Krishna Debnath
 
Molecular diagnostics of colorectal cancer
Molecular diagnostics   of colorectal cancerMolecular diagnostics   of colorectal cancer
Molecular diagnostics of colorectal cancer
Addisu Alemu
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
Robert J Miller MD
 
CES 2016 02 - Colorectal cancer
CES 2016 02 - Colorectal cancerCES 2016 02 - Colorectal cancer
CES 2016 02 - Colorectal cancer
Mauricio Lema
 
Askep ca colon inggris
Askep ca colon inggrisAskep ca colon inggris
Askep ca colon inggrisyusrawati
 
Staging an tumor markers
Staging an tumor markersStaging an tumor markers
Staging an tumor markers
DR DAVIS NADAKKAVUKARAN
 
Carcinoma of unknown primary
Carcinoma of unknown primaryCarcinoma of unknown primary
Carcinoma of unknown primary
Dr.Ofail Nadeem Alhusseiny
 
Management Of Retinoblastoma
Management Of Retinoblastoma  Management Of Retinoblastoma
Management Of Retinoblastoma
Dr Manas Dubey
 
carcinoma urinary bladder management
carcinoma urinary bladder management carcinoma urinary bladder management
carcinoma urinary bladder management
Isha Jaiswal
 
Radiogenomics of renal cell carcinoma
Radiogenomics of renal cell carcinomaRadiogenomics of renal cell carcinoma
Radiogenomics of renal cell carcinoma
Yulian Mytsyk
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerRHMBONCO
 
Medicine 5th year, 2nd lecture/part three (Dr. Abdulla Sharief)
Medicine 5th year, 2nd lecture/part three (Dr. Abdulla Sharief)Medicine 5th year, 2nd lecture/part three (Dr. Abdulla Sharief)
Medicine 5th year, 2nd lecture/part three (Dr. Abdulla Sharief)
College of Medicine, Sulaymaniyah
 
Thyroid tumors varun
Thyroid tumors varunThyroid tumors varun
Thyroid tumors varunVarun Goel
 
Urothelial carcinoma ( bladder cancer )
Urothelial carcinoma ( bladder cancer )Urothelial carcinoma ( bladder cancer )
Urothelial carcinoma ( bladder cancer )
Fikri Abdullah Zawawi
 

What's hot (20)

Urothelial ca urinary markers
Urothelial ca urinary markersUrothelial ca urinary markers
Urothelial ca urinary markers
 
Recent advances in colorectal carcinoma
Recent advances in colorectal carcinomaRecent advances in colorectal carcinoma
Recent advances in colorectal carcinoma
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
Renal cell carcinoma
Renal cell carcinomaRenal cell carcinoma
Renal cell carcinoma
 
Carcinoma of Unknown Primary (COUP)
Carcinoma of Unknown Primary (COUP)Carcinoma of Unknown Primary (COUP)
Carcinoma of Unknown Primary (COUP)
 
Carcinoma of unknown primary origin (cup) 198
Carcinoma of unknown primary origin (cup) 198Carcinoma of unknown primary origin (cup) 198
Carcinoma of unknown primary origin (cup) 198
 
Molecular diagnostics of colorectal cancer
Molecular diagnostics   of colorectal cancerMolecular diagnostics   of colorectal cancer
Molecular diagnostics of colorectal cancer
 
Cancer genetics
Cancer geneticsCancer genetics
Cancer genetics
 
CES 2016 02 - Colorectal cancer
CES 2016 02 - Colorectal cancerCES 2016 02 - Colorectal cancer
CES 2016 02 - Colorectal cancer
 
Askep ca colon inggris
Askep ca colon inggrisAskep ca colon inggris
Askep ca colon inggris
 
Staging an tumor markers
Staging an tumor markersStaging an tumor markers
Staging an tumor markers
 
Carcinoma of unknown primary
Carcinoma of unknown primaryCarcinoma of unknown primary
Carcinoma of unknown primary
 
Management Of Retinoblastoma
Management Of Retinoblastoma  Management Of Retinoblastoma
Management Of Retinoblastoma
 
carcinoma urinary bladder management
carcinoma urinary bladder management carcinoma urinary bladder management
carcinoma urinary bladder management
 
Radiogenomics of renal cell carcinoma
Radiogenomics of renal cell carcinomaRadiogenomics of renal cell carcinoma
Radiogenomics of renal cell carcinoma
 
Biology And Pathophysiology Of Cancer
Biology And Pathophysiology Of CancerBiology And Pathophysiology Of Cancer
Biology And Pathophysiology Of Cancer
 
Principles of Oncology
Principles of OncologyPrinciples of Oncology
Principles of Oncology
 
Medicine 5th year, 2nd lecture/part three (Dr. Abdulla Sharief)
Medicine 5th year, 2nd lecture/part three (Dr. Abdulla Sharief)Medicine 5th year, 2nd lecture/part three (Dr. Abdulla Sharief)
Medicine 5th year, 2nd lecture/part three (Dr. Abdulla Sharief)
 
Thyroid tumors varun
Thyroid tumors varunThyroid tumors varun
Thyroid tumors varun
 
Urothelial carcinoma ( bladder cancer )
Urothelial carcinoma ( bladder cancer )Urothelial carcinoma ( bladder cancer )
Urothelial carcinoma ( bladder cancer )
 

Viewers also liked

Bladder Cancer
Bladder CancerBladder Cancer
Bladder Cancer
shelbs531
 
Transitional cell carcinoma
Transitional cell carcinomaTransitional cell carcinoma
Transitional cell carcinomaairwave12
 
Cap protocol bladder
Cap protocol bladderCap protocol bladder
Cap protocol bladder
namrathrs87
 
Bladder Cancer NMIBC [Dr.Edmond Wong]
Bladder Cancer NMIBC [Dr.Edmond Wong]Bladder Cancer NMIBC [Dr.Edmond Wong]
Bladder Cancer NMIBC [Dr.Edmond Wong]
Edmond Wong
 
Bladder cancer
Bladder cancerBladder cancer
Transitional cell carcinoma
Transitional cell carcinomaTransitional cell carcinoma
Transitional cell carcinoma
Mohamed Shaaban
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
Amina Abdurahman
 
Latest Developments in Intravesical Therapy
Latest Developments in Intravesical Therapy Latest Developments in Intravesical Therapy
Latest Developments in Intravesical Therapy
BJUI
 
Overview of intravesical therapy: Current Controversies
Overview of intravesical therapy: Current ControversiesOverview of intravesical therapy: Current Controversies
Overview of intravesical therapy: Current Controversies
BJUI
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...European School of Oncology
 
Carcinoma urinary bladder
Carcinoma urinary bladderCarcinoma urinary bladder
Carcinoma urinary bladder
Musfirah Tahir
 
Transitional cell carcinoma of urinary bladeder
Transitional cell carcinoma of urinary bladederTransitional cell carcinoma of urinary bladeder
Transitional cell carcinoma of urinary bladeder
rezauro
 
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Edmond Wong
 
Case Report – Small Cell Carcinoma Bladder
Case Report – Small Cell Carcinoma BladderCase Report – Small Cell Carcinoma Bladder
Case Report – Small Cell Carcinoma Bladder
Kholiwe Skosana
 
Presentation march 2011 v1 e
Presentation march 2011 v1 ePresentation march 2011 v1 e
Presentation march 2011 v1 ekenj555
 
T1g3
T1g3T1g3

Viewers also liked (20)

Bladder Cancer
Bladder CancerBladder Cancer
Bladder Cancer
 
Transitional cell carcinoma
Transitional cell carcinomaTransitional cell carcinoma
Transitional cell carcinoma
 
Cap protocol bladder
Cap protocol bladderCap protocol bladder
Cap protocol bladder
 
Bladder Cancer NMIBC [Dr.Edmond Wong]
Bladder Cancer NMIBC [Dr.Edmond Wong]Bladder Cancer NMIBC [Dr.Edmond Wong]
Bladder Cancer NMIBC [Dr.Edmond Wong]
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
Transitional cell carcinoma
Transitional cell carcinomaTransitional cell carcinoma
Transitional cell carcinoma
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - GuidelinesW. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
 
Latest Developments in Intravesical Therapy
Latest Developments in Intravesical Therapy Latest Developments in Intravesical Therapy
Latest Developments in Intravesical Therapy
 
Overview of intravesical therapy: Current Controversies
Overview of intravesical therapy: Current ControversiesOverview of intravesical therapy: Current Controversies
Overview of intravesical therapy: Current Controversies
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
 
Carcinoma urinary bladder
Carcinoma urinary bladderCarcinoma urinary bladder
Carcinoma urinary bladder
 
Transitional cell carcinoma of urinary bladeder
Transitional cell carcinoma of urinary bladederTransitional cell carcinoma of urinary bladeder
Transitional cell carcinoma of urinary bladeder
 
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
Upper Tract Transitional Cell Carcinoma [Dr. Edmond Wong]
 
Case Report – Small Cell Carcinoma Bladder
Case Report – Small Cell Carcinoma BladderCase Report – Small Cell Carcinoma Bladder
Case Report – Small Cell Carcinoma Bladder
 
Superficial bladder cancer
Superficial bladder cancerSuperficial bladder cancer
Superficial bladder cancer
 
Presentation march 2011 v1 e
Presentation march 2011 v1 ePresentation march 2011 v1 e
Presentation march 2011 v1 e
 
T1g3
T1g3T1g3
T1g3
 

Similar to Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological cancers

Seminar on gi malig.pptx
Seminar on gi malig.pptxSeminar on gi malig.pptx
Seminar on gi malig.pptx
abhi23459
 
Management of Non Muscle Invasive Bladder Cancer
Management of Non Muscle Invasive Bladder CancerManagement of Non Muscle Invasive Bladder Cancer
Management of Non Muscle Invasive Bladder Cancer
Dr.Bhavin Vadodariya
 
Ampullary carcinoma
Ampullary carcinomaAmpullary carcinoma
Ampullary carcinoma
Dr Tauqeer A Siddiqui MD FACP
 
Staging and investigation of ca kidney and bladder
Staging and investigation of ca kidney and bladderStaging and investigation of ca kidney and bladder
Staging and investigation of ca kidney and bladder
AtulGupta369
 
pranaya ppt Management of nsgct
pranaya ppt Management of nsgctpranaya ppt Management of nsgct
pranaya ppt Management of nsgct
PRANAYA PANIGRAHI
 
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr RajeshTesticular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Rajesh Sinwer
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
Shazia Iqbal
 
Renal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRenal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRHMBONCO
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
Ministry of Health
 
Urology 5th year, 2nd lecture (Dr. Sarwar)
Urology 5th year, 2nd lecture (Dr. Sarwar)Urology 5th year, 2nd lecture (Dr. Sarwar)
Urology 5th year, 2nd lecture (Dr. Sarwar)
College of Medicine, Sulaymaniyah
 
Carcinoma esophagus 2020
Carcinoma esophagus 2020Carcinoma esophagus 2020
Carcinoma esophagus 2020
Dr.Anjali Reddy Baddiggam
 
Carcinoma stomach
Carcinoma stomachCarcinoma stomach
Carcinoma stomach
docatuljain
 
Pre management of carcinoma urinary bladder
Pre management of carcinoma urinary bladderPre management of carcinoma urinary bladder
Pre management of carcinoma urinary bladder
vrinda singla
 
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...European School of Oncology
 
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...European School of Oncology
 
Renal tumors
Renal tumorsRenal tumors
Renal tumors
ShrutiDevendra
 
Manik crc final
Manik crc finalManik crc final
Manik crc final
manik mandal
 
Colon cancer
Colon cancer Colon cancer
Colon cancer
Areej Abu Hanieh
 
Carcinoma stomach seminar
Carcinoma stomach seminarCarcinoma stomach seminar
Carcinoma stomach seminar
Rushabh Shah
 
Testicular tumor
Testicular tumorTesticular tumor
Testicular tumor
Faryal Tebani
 

Similar to Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological cancers (20)

Seminar on gi malig.pptx
Seminar on gi malig.pptxSeminar on gi malig.pptx
Seminar on gi malig.pptx
 
Management of Non Muscle Invasive Bladder Cancer
Management of Non Muscle Invasive Bladder CancerManagement of Non Muscle Invasive Bladder Cancer
Management of Non Muscle Invasive Bladder Cancer
 
Ampullary carcinoma
Ampullary carcinomaAmpullary carcinoma
Ampullary carcinoma
 
Staging and investigation of ca kidney and bladder
Staging and investigation of ca kidney and bladderStaging and investigation of ca kidney and bladder
Staging and investigation of ca kidney and bladder
 
pranaya ppt Management of nsgct
pranaya ppt Management of nsgctpranaya ppt Management of nsgct
pranaya ppt Management of nsgct
 
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr RajeshTesticular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
Testicular tumors-Cassification, Biomarkers and Staging by Dr Rajesh
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
Renal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And ManagementRenal Cell Carcinoma Diagnosis And Management
Renal Cell Carcinoma Diagnosis And Management
 
Bladder cancer
Bladder cancerBladder cancer
Bladder cancer
 
Urology 5th year, 2nd lecture (Dr. Sarwar)
Urology 5th year, 2nd lecture (Dr. Sarwar)Urology 5th year, 2nd lecture (Dr. Sarwar)
Urology 5th year, 2nd lecture (Dr. Sarwar)
 
Carcinoma esophagus 2020
Carcinoma esophagus 2020Carcinoma esophagus 2020
Carcinoma esophagus 2020
 
Carcinoma stomach
Carcinoma stomachCarcinoma stomach
Carcinoma stomach
 
Pre management of carcinoma urinary bladder
Pre management of carcinoma urinary bladderPre management of carcinoma urinary bladder
Pre management of carcinoma urinary bladder
 
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
 
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
Rare Solid Cancers: An Introduction - Slide 8 - I. Ray-Coquard - Rare female ...
 
Renal tumors
Renal tumorsRenal tumors
Renal tumors
 
Manik crc final
Manik crc finalManik crc final
Manik crc final
 
Colon cancer
Colon cancer Colon cancer
Colon cancer
 
Carcinoma stomach seminar
Carcinoma stomach seminarCarcinoma stomach seminar
Carcinoma stomach seminar
 
Testicular tumor
Testicular tumorTesticular tumor
Testicular tumor
 

More from European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...European School of Oncology
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasEuropean School of Oncology
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasEuropean School of Oncology
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineEuropean School of Oncology
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...European School of Oncology
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer European School of Oncology
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerEuropean School of Oncology
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artEuropean School of Oncology
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...European School of Oncology
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artEuropean School of Oncology
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...European School of Oncology
 
J.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artJ.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artEuropean School of Oncology
 
R. Gaafar - Lung cancer - Guidelines and clinical case presentation (2-3 cases)
R. Gaafar - Lung cancer - Guidelines and clinical case presentation (2-3 cases)R. Gaafar - Lung cancer - Guidelines and clinical case presentation (2-3 cases)
R. Gaafar - Lung cancer - Guidelines and clinical case presentation (2-3 cases)European School of Oncology
 

More from European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
 
1 azim
1 azim1 azim
1 azim
 
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the artH. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
 
J.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artJ.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the art
 
R. Gaafar - Lung cancer - Guidelines and clinical case presentation (2-3 cases)
R. Gaafar - Lung cancer - Guidelines and clinical case presentation (2-3 cases)R. Gaafar - Lung cancer - Guidelines and clinical case presentation (2-3 cases)
R. Gaafar - Lung cancer - Guidelines and clinical case presentation (2-3 cases)
 
G. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the artG. Ceresoli - Lung cancer - State of the art
G. Ceresoli - Lung cancer - State of the art
 

Rare Solid Cancers: An Introduction - Slide 10 - V. Kataja - Rare urological cancers

  • 1. Rare Urological Cancers Professor Vesa V Kataja Head of Department Cancer Center, UEF / KUH Kuopio, FINLAND Kuopio University Hospital
  • 2.
  • 3.
  • 4.
  • 5. Rare Renal Cancers *Not in WHO 2004 classification Histological subtypes of sporadic renal cell cancer Histology/Entity Prognosis Note End-stage renal disease associated carcinoma* 40 – 100 x the risk of general population Depends on histopathological subtype Spectrum of recognised types Two novel neoplasia 1) Cystic disease associated RCC 2) Papillary clear cell RCC Follicular RC* Good Note! metastatic follicular carcinoma of the thyroid Clear cell papillary and cystic RCC* Excellent TFE3 negative Oncocytic papillary RCC* Not established; mainly on better side Genetically similar to papillary RCC type 1 and 2 (trisomy 7, 17, loss of Y in FISH); male predominance (87 %)
  • 6. Umberto Capitanio et al., BJU Int 103:1496-1500;2009
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13. Rare Urothelial Bladder Cancers Variants of invasive urothelial carcinoma Squamous differentiation Glandular differentiation Nested pattern Microcystic Micropapillary Lymphoepithelioma-like Plasmacytoid and lymphoma-like Sarcomatoid/carcinosarcoma Giant cell Trophoblastic differentiation Clear cell Lipid cell Undifferentiated Adapted from the World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs Compared to pure urothelial cancers: - Higher clinical stage at presentation - More likely to be invasive
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.

Editor's Notes

  1. Rare Cancer = rare in location / rare histology in a common location
  2. Histology matters! Prognosis defined by histopathological subtype